Diagnostic strategies for autosomal dominant acute porphyrias: retrospective analysis of 467 unrelated patients referred for mutational analysis of the HMBS, CPOX, or PPOX gene.

BACKGROUND Clinically indistinguishable attacks of acute porphyria occur in acute intermittent porphyria (AIP), hereditary coproporphyria (HCP), and variegate porphyria (VP). There are few evidence-based diagnostic strategies for these disorders. METHODS The diagnostic sensitivity of mutation detection was determined by sequencing and gene-dosage analysis to search for mutations in 467 sequentially referred, unrelated patients. The diagnostic accuracy of plasma fluorescence scanning, fecal porphyrin analysis, and porphobilinogen deaminase (PBGD) assay was assessed in mutation-positive patients (AIP, 260 patients; VP, 152 patients; HCP, 31 patients). RESULTS Sensitivities (95% CI) for mutation detection were as follows: AIP, 98.1% (95.6%-99.2%); HCP, 96.9% (84.3%-99.5%); VP, 100% (95.7%-100%). We identified 5 large deletions in the HMBS gene (hydroxymethylbilane synthase) and one in the CPOX gene (coproporphyrinogen oxidase). The plasma fluorescence scan was positive more often in VP (99% of patients) than in AIP (68%) or HCP (29%). The wavelength of the fluorescence emission peak and the fecal coproporphyrin isomer ratio had high diagnostic specificity and sensitivity for differentiating between AIP, HCP, and VP. DNA analysis followed by PBGD assay in mutation-negative patients had greater diagnostic accuracy for AIP than either test alone. CONCLUSIONS When PBG excretion is increased, 2 investigations (plasma fluorescence scanning, the coproporphyrin isomer ratio) are sufficient, with rare exceptions, to identify the type of acute porphyria. When the results of PBG, 5-aminolevulinate, and porphyrin analyses are within reference intervals and clinical suspicion that a past illness was caused by an acute porphyria remains high, mutation analysis of the HMBS gene followed by PBGD assay is an effective strategy for diagnosis or exclusion of AIP.

[1]  E. Rossi.  Increased fecal porphyrins in acute intermittent porphyria. , 1999, Clinical chemistry.

[2]  P. Meissner,et al.  Plasma fluorescence scanning and fecal porphyrin analysis for the diagnosis of variegate porphyria: precise determination of sensitivity and specificity with detection of protoporphyrinogen oxidase mutations as a reference standard. , 2004, Clinical chemistry.

[3]  E. B. Wilson.  Probable Inference, the Law of Succession, and Statistical Inference , 1927 .

[4]  S. Sassa.  Modern diagnosis and management of the porphyrias , 2006, British journal of haematology.

[5]  Edward R. Ashwood,et al.  Tietz Textbook of Clinical Chemistry and Molecular Diagnostics , 2005 .

[6]  M. Cappellini,et al.  A large deletion on chromosome 11 in acute intermittent porphyria. , 2006, Blood cells, molecules & diseases.

[7]  M. Anvret,et al.  Identification of the most common mutation within the porphobilinogen deaminase gene in Swedish patients with acute intermittent porphyria. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Deybach,et al.  Characterization of mutations in the CPO gene in British patients demonstrates absence of genotype-phenotype correlation and identifies relationship between hereditary coproporphyria and harderoporphyria. , 2001, American journal of human genetics.

[9]  R. Day,et al.  The clinical and biochemical features of variegate porphyria: an analysis of 300 cases studied at Groote Schuur Hospital, Cape Town. , 1980, The International journal of biochemistry.

[10]  S. Granick,et al.  THE OCCURRENCE AND DETERMINATION OF δ-AMINOLEVULINIC ACID AND PORPHOBILINOGEN IN URINE , 1956 .

[11]  A. Corrigall,et al.  A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria , 1996, Nature Genetics.

[12]  P. Meissner,et al.  An Analysis of 112 Acute Porphyric Attacks in Cape Town, South Africa: Evidence That Acute Intermittent Porphyria and Variegate Porphyria Differ in Susceptibility and Severity , 2005, Medicine.

[13]  R. Kauppinen,et al.  A novel 19‐bp deletion of exon 15 in the HMBS gene causing acute intermittent porphyria associating with rhabdomyolysis during an acute attack , 2008, Clinical genetics.

[14]  Roger Guilard,et al.  The porphyrin handbook , 2002 .

[15]  S. Ratnaike,et al.  Fecal coproporphyrin isomers in hereditary coproporphyria. , 1992, Clinical chemistry.

[16]  C. Lim,et al.  Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias. , 1984, Clinica chimica acta; international journal of clinical chemistry.

[17]  E. Kostrzewska,et al.  Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria. , 1986, Annals of clinical research.

[18]  C. Möller,et al.  Variations in porphobilinogen and 5-aminolevulinic acid concentrations in plasma and urine from asymptomatic carriers of the acute intermittent porphyria gene with increased porphyrin precursor excretion. , 2006, Clinical chemistry.

[19]  M. von Und Zu Fraunberg,et al.  Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families. , 2002, Clinical chemistry.

[20]  Matthew D. Dyer,et al.  Human genomic deletions mediated by recombination between Alu elements. , 2006, American journal of human genetics.

[21]  S. Granick,et al.  The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine. , 1956, The Journal of biological chemistry.

[22]  R. Kauppinen.  Molecular diagnostics of acute intermittent porphyria , 2004, Expert review of molecular diagnostics.

[23]  M. Badminton,et al.  Gene dosage analysis identifies large deletions of the FECH gene in 10% of families with erythropoietic protoporphyria. , 2007, The Journal of investigative dermatology.

[24]  J. Barth,et al.  Hereditary coproporphyria: Comparison of molecular and biochemical investigations in a large family , 2005, Journal of Inherited Metabolic Disease.

[25]  J. Deybach,et al.  Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria. , 1997, American journal of human genetics.

[26]  C. Darby,et al.  Hereditary coproporphyria: report of an Irish kindred and identification of a novel gene mutation. , 2008, Irish medical journal.

[27]  A. Batlle,et al.  Genetic and biochemical studies in Argentinean patients with variegate porphyria , 2008, BMC Medical Genetics.

[28]  C. Magnussen,et al.  A red cell enzyme method for the diagnosis of acute intermittent porphyria. , 1974, Blood.

[29]  E. Rossi,et al.  Rapid procedure for fecal porphyrin assay. , 1985, Clinical chemistry.

[30]  K. Jacob,et al.  Studies on coproporphyrin isomers in urine and feces in the porphyrias. , 1999, Clinica chimica acta; international journal of clinical chemistry.

[31]  R. Newcombe,et al.  Detection of latent variegate porphyria by fluorescence emission spectroscopy of plasma , 1993, The British journal of dermatology.

[32]  X. Schneider-Yin,et al.  Characterization of two missense variants in the hydroxymethylbilane synthase gene in the Israeli population, which differ in their associations with acute intermittent porphyria. , 2008, Molecular genetics and metabolism.

[33]  H. Puy,et al.  May 2006 update in porphobilinogen deaminase gene polymorphisms and mutations causing acute intermittent porphyria: comparison with the situation in Slavic population. , 2006, Physiological research.

[34]  P. Harper,et al.  Porphyrins, porphyrin metabolism and porphyrias. II. Diagnosis and monitoring in the acute porphyrias. , 2000, Scandinavian journal of clinical and laboratory investigation.

[35]  H. Bonkovsky,et al.  Diagnosis of Porphyric Syndromes: A Practical Approach in the Era of Molecular Biology , 1998, Seminars in liver disease.

[36]  G. Elder,et al.  Non-erythroid form of acute intermittent porphyria caused by promoter and frameshift mutations distant from the coding sequence of exon 1 of the HMBS gene , 2000, Human Genetics.

[37]  G. Elder,et al.  Comparison of complementary and genomic DNA sequencing for the detection of mutations in the HMBS gene in British patients with acute intermittent porphyria: identification of 25 novel mutations , 1999, Human Genetics.

[38]  D. Stephenson,et al.  HMBS Mutations in Chinese Patients with Acute Intermittent Porphyria , 2008, Annals of human genetics.

[39]  M Nurminen,et al.  Comparative analysis of two rates. , 1985, Statistics in medicine.

[40]  J. Deybach,et al.  Variegate porphyria in Western Europe: identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation. , 1999, American journal of human genetics.